McKesson Corporation (MCK) Financials
Key financial figures for McKesson Corporation (Q1 2027).
McKesson raised its full-year adjusted EPS guidance to $44.20-$45.00 after Q1 FY2027 revenue grew 8% to $105.4 billion and adjusted EPS rose 20% to $9.93, led by the North American Pharmaceutical and Oncology & Multispecialty segments. Q1 FY2027 revenue was $105.4 billion, up 8% year over year, driven by growth in the North American Pharmaceutical and Oncology & Multispecialty segments. GAAP diluted EPS fell to $5.15 from $6.25 a year ago, mainly due to a $293 million redemption value adjustment tied to redeemable non-controlling interests in the Medical-Surgical Solutions segment. Adjusted EPS grew 20% to $9.93, driven by strong operational growth led by North American Pharmaceutical and Oncology & Multispecialty, plus a lower share count. On the outlook: Raised FY2027 Adjusted Earnings per Diluted Share guidance to $44.20 to $45.00, up from the prior range of $43.80 to $44.60. Figures are for Q1 FY2027, as McKesson Corporation reported them.
- Revenue
- $105.4B
- Net Income
- $1.0B
- EPS
- $5.17
- Total Assets
- $88.3B
- Operating Cash Flow
- -$220M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q1 FY2027 | $105.4B | $614M | $5.15 | 1.25% | -$332M |
| Q4 FY2026 | $96.3B | $1.7B | $13.71 | 2.33% | $3.2B |
| Q3 FY2026 | $106.2B | $1.2B | $9.59 | 1.53% | $1.1B |
| Q2 FY2026 | $103.2B | $1.1B | $8.92 | 1.42% | $2.2B |
| Q1 FY2026 | $97.8B | $784M | $6.25 | 1.06% | -$1.1B |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2026 | $403.4B | $4.8B | $38.38 | 1.6% | $5.4B |
| FY2025 | $359.1B | $3.3B | $25.72 | 1.22% | $5.2B |
| FY2024 | $309.0B | $3.0B | $22.39 | 1.27% | $3.6B |
Frequently asked questions
What was McKesson Corporation's revenue last quarter?
McKesson Corporation reported revenue of $105.38 billion for Q1 FY2027, up 7.7% from the same period a year earlier.
Is McKesson Corporation profitable?
Yes. McKesson Corporation reported net income of $614.0 million for Q1 FY2027, a net margin of 0.58% on revenue.
How has McKesson Corporation's margin trended?
Operating margin was 1.25% in Q1 FY2027, compared with 1.06% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did McKesson Corporation generate?
McKesson Corporation generated free cash flow of -$332.0 million in Q1 FY2027, after capital expenditure.
Full income statement, balance sheet and cash flow for McKesson Corporation on SentiSense, with up to forty quarters and twenty fiscal years of history.